Clinical trials
Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
282 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 22 |
| 2020 | 17 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 29 |
| 2024 | 22 |
| 2025 | 31 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 78 |
| Completed | 77 |
| Unknown status | 32 |
| Active, not recruiting | 29 |
| Not yet recruiting | 29 |
| Terminated | 23 |
| Withdrawn | 11 |
| Available | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 11 |
| Mansoura University | 10 |
| ImmunityBio, Inc. | 7 |
| Janssen Research & Development, LLC | 7 |
| CG Oncology, Inc. | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Pfizer | 4 |
| Protara Therapeutics | 4 |
| University of Rome Tor Vergata | 4 |
| AstraZeneca | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 282 |
| Urinary Bladder Neoplasms | 146 |
| Carcinoma, Transitional Cell | 26 |
| Neoplasms | 23 |
| Recurrence | 22 |
| Carcinoma in Situ | 18 |
| Urologic Neoplasms | 15 |
| Urinary Bladder Diseases | 11 |
| Disease Progression | 10 |
| Urologic Diseases | 9 |
Trials
Showing 1 to 25 of 282. Each trial links to its page on Pharma Observatory.
182 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.